Sara McMahon

Sara McMahon

Auto-generated profile, based on publicly available information

Sara McMahon

Ventana Medical Systems, Inc./Roche Tissue Diagnostics, Tucson, Arizona

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
RGRondell P. Graham
Rondell P. Graham
SMSara McMahon
Sara McMahon
EAEze Ahanonu
Eze Ahanonu
QSQian Shi
Qian Shi
FSFrank Sinicrope
Frank Sinicrope
Purpose: Targeting the programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) interaction has led to durable responses in fewer than half of patients with mismatch repair–deficient (MMR-d) advanced colorectal cancers. Immune contexture, including spatial distribution of immune cells in the tumor microenvironment (TME), may predict immunotherapy outcome. Experimental Design: Immune contexture and spatial distribution, including cell-to-cell distance measurements, were analyzed by multiplex immunofluorescence (mIF) in primary colorectal cancers with d-MMR (N = 33) from patients treated with anti–PD-1 antibodies. By digital image analysis, density, ratio, intensity, and spatial distribution of PD-L1, PD-1, CD8, CD3, CD68, LAG3, TGFβR2, MHC-I, CD14, B2M, and pan-cytokeratin were computed. Feature selection was performed by regularized Cox regression with LASSO, and a proportional hazards model was fitted to predict progression-free survival (PFS). Results: For predicting survival among patients with MMR-d advanced colorectal cancer receiving PD-1 blockade, cell-to-cell distance measurements, but not cell densities or ratios, achieved statistical significance univariately. By multivariable feature selection, only mean number of PD-1+ cells within 10 μm of a PD-L1+ cell was significantly predictive of PFS. Dichotomization of this variable revealed that those with high versus low values had significantly prolonged PFS [median not reached (>83 months) vs. 8.5 months (95% confidence interval (95% CI), 4.7–NR)] with a median PFS of 28.4 months for all patients [adjusted HR (HRadj) = 0.14; 95% CI, 0.04–0.56; P = 0.005]. Expression of PD-1 was observed on CD8+ T cells; PD-L1 on CD3+ and CD8+ T lymphocytes, macrophages (CD68+), and tumor cells. Conclusions: In d-MMR colorectal cancers, PD-1+ to PD-L1+ receptor to ligand proximity is a potential predictive biomarker for the effectiveness of PD-1 blockade.

25 November 2025
Verified
Other
Open access
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
RGRondell P. Graham
Rondell P. Graham
SMSara McMahon
Sara McMahon
EAEze Ahanonu
Eze Ahanonu
QSQian Shi
Qian Shi
FSFrank Sinicrope
Frank Sinicrope
Supplementary Table S2. Significant features in the univariable analysis for prediction of tumor response.

25 November 2025
Verified
Other
Open access
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
RGRondell P. Graham
Rondell P. Graham
SMSara McMahon
Sara McMahon
EAEze Ahanonu
Eze Ahanonu
QSQian Shi
Qian Shi
FSFrank Sinicrope
Frank Sinicrope
Supplementary Figure S1. PD-L1 (green) was expressed in (A) CD3+ T lymphocytes (magenta/pink), (B) CD68+ macrophages (red), panCK+ (cyan/light blue) tumor cells, and (C) tumor cells (red). PD-1 expression on CD8+ T lymphocytes was also observed.

13 October 2023
Verified
Other
Open access
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
RGRondell P. Graham
Rondell P. Graham
SMSara McMahon
Sara McMahon
EAEze Ahanonu
Eze Ahanonu
QSQian Shi
Qian Shi
FSFrank Sinicrope
Frank Sinicrope
Purpose:Targeting the programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) interaction has led to durable responses in fewer than half of patients with mismatch repair–deficient (MMR-d) advanced colorectal cancers. Immune contexture, including spatial distribution of immune cells in the tumor microenvironment (TME), may predict immunotherapy outcome.Experimental Design:Immune contexture and spatial distribution, including cell-to-cell distance measurements, were analyzed by multiplex immunofluorescence (mIF) in primary colorectal cancers with d-MMR (N = 33) from patients treated with anti–PD-1 antibodies. By digital image analysis, density, ratio, intensity, and spatial distribution of PD-L1, PD-1, CD8, CD3, CD68, LAG3, TGFβR2, MHC-I, CD14, B2M, and pan-cytokeratin were computed. Feature selection was performed by regularized Cox regression with LASSO, and a proportional hazards model was fitted to predict progression-free survival (PFS).Results:For predicting survival among patients with MMR-d advanced colorectal cancer receiving PD-1 blockade, cell-to-cell distance measurements, but not cell densities or ratios, achieved statistical significance univariately. By multivariable feature selection, only mean number of PD-1+ cells within 10 μm of a PD-L1+ cell was significantly predictive of PFS. Dichotomization of this variable revealed that those with high versus low values had significantly prolonged PFS [median not reached (>83 months) vs. 8.5 months (95% confidence interval (95% CI), 4.7–NR)] with a median PFS of 28.4 months for all patients [adjusted HR (HRadj) = 0.14; 95% CI, 0.04–0.56; P = 0.005]. Expression of PD-1 was observed on CD8+ T cells; PD-L1 on CD3+ and CD8+ T lymphocytes, macrophages (CD68+), and tumor cells.Conclusions:In d-MMR colorectal cancers, PD-1+ to PD-L1+ receptor to ligand proximity is a potential predictive biomarker for the effectiveness of PD-1 blockade.

13 October 2023
Verified
Other
Open access
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
RGRondell P. Graham
Rondell P. Graham
SMSara McMahon
Sara McMahon
EAEze Ahanonu
Eze Ahanonu
QSQian Shi
Qian Shi
FSFrank Sinicrope
Frank Sinicrope
Purpose:Targeting the programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) interaction has led to durable responses in fewer than half of patients with mismatch repair–deficient (MMR-d) advanced colorectal cancers. Immune contexture, including spatial distribution of immune cells in the tumor microenvironment (TME), may predict immunotherapy outcome.Experimental Design:Immune contexture and spatial distribution, including cell-to-cell distance measurements, were analyzed by multiplex immunofluorescence (mIF) in primary colorectal cancers with d-MMR (N = 33) from patients treated with anti–PD-1 antibodies. By digital image analysis, density, ratio, intensity, and spatial distribution of PD-L1, PD-1, CD8, CD3, CD68, LAG3, TGFβR2, MHC-I, CD14, B2M, and pan-cytokeratin were computed. Feature selection was performed by regularized Cox regression with LASSO, and a proportional hazards model was fitted to predict progression-free survival (PFS).Results:For predicting survival among patients with MMR-d advanced colorectal cancer receiving PD-1 blockade, cell-to-cell distance measurements, but not cell densities or ratios, achieved statistical significance univariately. By multivariable feature selection, only mean number of PD-1+ cells within 10 μm of a PD-L1+ cell was significantly predictive of PFS. Dichotomization of this variable revealed that those with high versus low values had significantly prolonged PFS [median not reached (>83 months) vs. 8.5 months (95% confidence interval (95% CI), 4.7–NR)] with a median PFS of 28.4 months for all patients [adjusted HR (HRadj) = 0.14; 95% CI, 0.04–0.56; P = 0.005]. Expression of PD-1 was observed on CD8+ T cells; PD-L1 on CD3+ and CD8+ T lymphocytes, macrophages (CD68+), and tumor cells.Conclusions:In d-MMR colorectal cancers, PD-1+ to PD-L1+ receptor to ligand proximity is a potential predictive biomarker for the effectiveness of PD-1 blockade.

16 September 2024
Verified
Other
Open access
PDF file
BSBahar Saberzadeh-Ardestani
Bahar Saberzadeh-Ardestani
RGRondell P. Graham
Rondell P. Graham
SMSara McMahon
Sara McMahon
EAEze Ahanonu
Eze Ahanonu
QSQian Shi
Qian Shi
FSFrank Sinicrope
Frank Sinicrope
Supplementary Figure S2. (A) Distribution of mean number of PD-1 + cells within 10 μm of a PDL1+ cell in the overall tumor; (B) range of possible cutoff values and corresponding hazard ratios.